Literature DB >> 25454299

The ins and outs of liver imaging.

Erin K O'Neill1, Jonathan R Cogley2, Frank H Miller3.   

Abstract

Different imaging modalities including ultrasonography, computed tomography (CT), and MR imaging may be used in the liver depending on the clinical situation. The ability of dedicated contrast-enhanced liver MR imaging or CT to definitively characterize lesions as benign is crucial in avoiding unnecessary biopsy. Liver imaging surveillance in patients with cirrhosis may allow for detection of hepatocellular carcinoma at an earlier stage, and therefore may improve outcome. This article reviews the different imaging modalities used to evaluate the liver and focal benign and malignant hepatic lesions, and the basic surveillance strategy for patients at increased risk for hepatocellular carcinoma.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cholangiocarcinoma; Elastography; Focal nodular hyperplasia; Hemangioma; Hepatic adenoma; Hepatocellular carcinoma; Imaging; Liver

Mesh:

Substances:

Year:  2014        PMID: 25454299     DOI: 10.1016/j.cld.2014.09.006

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  9 in total

1.  Hepatobiliary Quiz Answers-19 (2016).

Authors:  Sahaj Rathi; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2016-10-03

Review 2.  Liver Masses: What Physicians Need to Know About Ordering and Interpreting Liver Imaging.

Authors:  Arman Sheybani; Ron C Gaba; R Peter Lokken; Senta M Berggruen; Winnie A Mar
Journal:  Curr Gastroenterol Rep       Date:  2017-10-18

Review 3.  Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Authors:  Mirella Fraquelli; Tin Nadarevic; Agostino Colli; Cristina Manzotti; Vanja Giljaca; Damir Miletic; Davor Štimac; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2022-09-02

Review 4.  Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Authors:  Tin Nadarevic; Vanja Giljaca; Agostino Colli; Mirella Fraquelli; Giovanni Casazza; Damir Miletic; Davor Štimac
Journal:  Cochrane Database Syst Rev       Date:  2021-10-06

5.  S2FLNet: Hepatic steatosis detection network with body shape.

Authors:  Qiyue Wang; Wu Xue; Xiaoke Zhang; Fang Jin; James Hahn
Journal:  Comput Biol Med       Date:  2021-11-30       Impact factor: 6.698

Review 6.  Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Authors:  Tin Nadarevic; Agostino Colli; Vanja Giljaca; Mirella Fraquelli; Giovanni Casazza; Cristina Manzotti; Davor Štimac; Damir Miletic
Journal:  Cochrane Database Syst Rev       Date:  2022-05-06

7.  Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Authors:  Agostino Colli; Tin Nadarevic; Damir Miletic; Vanja Giljaca; Mirella Fraquelli; Davor Štimac; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2021-04-15

8.  Automated segmentation of liver segment on portal venous phase MR images using a 3D convolutional neural network.

Authors:  Xinjun Han; Xinru Wu; Dawei Yang; Zhenghan Yang; Shuhui Wang; Lixue Xu; Hui Xu; Dandan Zheng; Niange Yu; Yanjie Hong; Zhixuan Yu
Journal:  Insights Imaging       Date:  2022-02-24

Review 9.  Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging and Multidetector-Row Computed Tomography for the Diagnosis of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.

Authors:  Feng Ye; Jun Liu; Han Ouyang
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.